Neonatal myocarditis due to Coxsackie: case report and literature review
DOI:
https://doi.org/10.5281/zenodo.10998879Keywords:
Early Diagnosis, Prognosis, Coxsackievirus Infections, Newborn, MyocarditisAbstract
This article aims to elucidate viral myocarditis in neonates, focusing on a case involving Coxsackie virus, in order to enhance early detection and treatment, and, therefore, mitigating the substantial morbidity and mortality associated with this condition. Our study details the clinical course of a female newborn with Coxsackievirus-induced myocarditis, who underwent diagnostic modalities such as echocardiogram, cardiac magnetic resonance, and serial biomarker analysis, all of which allowed us to outline the disease's natural progression and its response to intervention over time. Based on a literature review we identified 6 similar cases, spanning from 1962 to 2022. In this analysis we assessed clinical presentation, diagnostic methodologies, treatment strategies, and prognostic outcomes, drawing comparisons between our case and reported instances. The objective is to highlight optimal clinical practices for managing this pathology effectively. Furthermore, we approach the pivotal role of early diagnosis and its impact on disease prognosis. We emphasize that, though rare, viral myocarditis in neonates can lead to a high rate of mortality, which is why a prompt diagnosis and an appropriate intervention are imperative to improve the outcome.
Downloads
References
Noites I, Soares P Miranda JO, et al. Neonatal cardiomyopathy: a 20-year overview of a reference centre. Journal of Pediatric and Neonatal Individualized Medicine. 2020;9(1):e090129. doi: 10.7363/090129.
Lipshultz SE, Law YM, Asante-Korang A, et al. Cardiomyopathy in Children: Classification and Diagnosis: A Scientific Statement From the American Heart Association. Circulation. 2019;140(1):e9-e68. doi: 10.1161/CIR.0000000000000682.
Law YM, Lal AK, Chen S, et al.; American Heart Association Pediatric Heart Failure and Transplantation Committee of the Council on Lifelong Congenital Heart Disease and Heart Health in the Young and Stroke Council. Diagnosis and Management of Myocarditis in Children: A Scientific Statement From the American Heart Association. Circulation. 2021;144(6):e123-35. doi: 10.1161/CIR.0000000000001001.
Ng KF, Gibb J, Struik S, et al.; Neonatal Enteroviral Myocarditis Consortium. Remember the heart: neonatal myocarditis. Arch Dis Child. 2023;108(5):417-9. doi: 10.1136/archdischild-2023-325316.
Bejiqi R, Retkoceri R, Maloku A, et al. The Diagnostic and Clinical Approach to Pediatric Myocarditis: A Review of the Current Literature. Open Access Maced J Med Sci. 2019;7(1):162-73. doi: 10.3889/oamjms.2019.010.
Jennings RC. Coxsackie group B fatal neonatal myocarditis associated with cardiomegaly. J Clin Pathol. 1966;19(4):325-7. doi: 10.1136/jcp.19.4.325.
Storm KK, De Herdt D, Couderé K, et al.; VIRO-TypeNed. Severe neonatal enterovirus infection in twins with different outcomes: A case report. Front Pediatr. 2023 Sep;11:1181698. doi: 10.3389/fped.2023.1181698.
Tseng JJ, Lin CH, Lin MC. Long-Term Outcomes of Pediatric Enterovirus Infection in Taiwan: A Population-Based Cohort Study. Front Pediatr. 2020;8:285. doi: 10.3389/fped.2020.00285.
Bansal M. Myocardial disorders in the neonate. NeoReviews. 2018;19(7):e403-9. doi: 10.1542/neo.19-7-e403.
Chuang YY, Huang YC. Enteroviral infection in neonates. J Microbiol Immunol Infect. 2019;52(6):851-7. doi: 10.1016/j.jmii.2019.08.018.
Annoni G, De Rienzo F, Nonini S, et al. Enterovirus fulminant myocarditis as cause of acute heart failure in a newborn. Int J Cardiol Heart Vasc. 2022;42:101093. doi: 10.1016/j.ijcha.2022.101093.
Sandoni M, Ciardo L, Tamburini C, et al. Enteroviral Infections in the First Three Months of Life. Pathogens. 2022;11(1):60. doi: 10.3390/pathogens11010060.
Schwartz BH, Stein NR, Eshaghian S, et al. Recurrent Myocarditis Treated with Intravenous Immune Globulin and Steroids. Am J Case Rep. 2022;23:e935974. doi: 10.12659/AJCR.935974.
Yen CY, Hung MC, Wong YC, et al. Role of intravenous immunoglobulin therapy in the survival rate of pediatric patients with acute myocarditis: A systematic review and meta-analysis. Sci Rep. 2019;9(1):10459. doi: 10.1038/s41598-019-46888-0.
Zhang M, Wang H, Tang J, et al. Clinical characteristics of severe neonatal enterovirus infection: a systematic review. BMC Pediatr. 2021;21(1):127. doi: 10.1186/s12887-021-02599-y.
Putschoegl A, Auerbach S. Diagnosis, evaluation, and treatment of myocarditis in children. Pediatric Clinics. 2020;67(5):855-74. doi: 10.1016/j.pcl.2020.06.013.
Singanayagam A, Moore C, Froude S, et al. Increased reports of severe myocarditis associated with enterovirus infection in neonates, United Kingdom, 27 June 2022 to 26 April 2023. Euro Surveill. 2023;28(39):2300313. doi: 10.2807/1560-7917.ES.2023.28.39.2300313.
Ning J. Disease Not To Be Ignored: The Second Viremia of Coxsackie. The Pediatric Infectious Disease Journal. 2023;42(4):e134-5. doi: 10.1097/INF.0000000000003821.
Singh S, Mane SS, Kasniya G, et al. Enteroviral Infections in Infants. Newborn (Clarksville). 2022;1(3):297-305. doi: 10.5005/jp-journals-11002-0036.
Chang YJ, Hsiao HJ, Hsia SH, et al. Analysis of clinical parameters and echocardiography as predictors of fatal pediatric myocarditis. PLoS One. 2019;14(3):e0214087. doi: 10.1371/journal.pone.0214087.
Zanatta A, Carturan E, Rizzo S, et al. Story telling of myocarditis. Int J Cardiol. 2019;294:61-64. doi: 10.1016/j.ijcard.2019.07.046.
Robino G, Perlman A, Togo Y, et al. Fatal neonatal infection due to Coxsackie B2 virus. Report of generalized infection and myocarditis in the newborn. J Pediatr. 1962;61:911-8. doi: 10.1016/s0022-3476(62)80205-4.
Lu JC, Koay KW, Ramers CB, et al. Neonate with coxsackie B1 infection, cardiomyopathy and arrhythmias. J Natl Med Assoc. 2005;97(7):1028-30.
De Vetten L, Bergman KA, Elzenga NJ, et al. Neonatal myocardial infarction or myocarditis? Pediatr Cardiol. 2011;32(4):492-7. doi: 10.1007/s00246-010-9865-8.
Tanabe T, Osaki M, Sato K, et al. Neonatal myocarditis that needed to be differentiated from myocardial ischemia. Pediatr Int. 2022;64(1):e14739. doi: 10.1111/ped.14739.
Savorgnan F, Checchia PA. Medical Management of Acute Fulminant Myocarditis. Pediatric Critical Care: Current Controversies. 2019:85-96. doi: 10.1007/978-3-319-96499-7_5.
Inwald D, Franklin O, Cubitt D, et al. Enterovirus myocarditis as a cause of neonatal collapse. Arch Dis Child Fetal Neonatal Ed. 2004;89(5):F461-2. doi: 10.1136/adc.2003.034439.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Revista Médica del Instituto Mexicano del Seguro Social
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors retain their copyright and grant the Revista Médica del IMSS the right of first publication. Articles are distributed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which allows sharing as long as the author and the original source are properly credited.
